15 results on '"Barnacle, Helen"'
Search Results
2. Reply: “FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease” and “Triple Therapy in Chronic Obstructive Pulmonary Disease”
3. An Oral Inhibitor of p38 MAP Kinase Reduces Plasma Fibrinogen in Patients With Chronic Obstructive Pulmonary Disease
4. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma
5. Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD
6. Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease
7. Clinically important deterioration in advanced COPD patients using single inhaler triple therapy: results from the FULFIL study
8. Single inhaler triple therapy in patients with advanced COPD (FULFIL): exacerbation/pneumonia composite outcomes
9. Single inhaler triple therapy in patients with advanced COPD: healthcare resource utilisation and cost data from the FULFIL study
10. Population pharmacokinetic (PK) analysis of fluticasone furoate (FF)/umeclidimium (UMEC)/vilanterol (VI) via a single inhaler in patients with COPD (FULFIL)
11. Single inhaler triple therapy in advanced COPD patients: prior medication and disease severity FULFIL subanalyses
12. FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease
13. LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial
14. A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol
15. Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.